期刊文献+

纳米氧化铈在医药领域中的应用研究进展 被引量:4

Research Progress on Application of Cerium Oxide Nanoparticles in Medicine
原文传递
导出
摘要 纳米氧化铈作为金属氧化物纳米颗粒中重要的一员,通过与氧原子的可逆结合以及氧空位的存在,在Ce3+和Ce4+之间不断循环转换,使其具有氧化还原的双重特性。由于其特殊的物理化学性质,纳米氧化铈作为一种用途广泛的纳米材料得到广泛的关注,尤其是在医药领域方面。越来越多研究表明纳米氧化铈具有抗氧化、抗肿瘤、抗菌及神经保护等作用,这些作用通过模拟天然酶活性、诱导肿瘤细胞凋亡、抑制异常血管生长、破坏细菌细胞壁、清除活性氧等作用机制来实现。本文综述了纳米氧化铈在医药领域方面的应用,以期为纳米氧化铈生物医学研究和临床应用提供参考。 Cerium oxide nanoparticles as an important member of metal oxide nanoparticles, through the reversible combination with oxygen atoms and the existence of oxygen vacancies, it continuously switches between Ce3+ and Ce4+, make it have the dual characteristic of redox. Because of its special physical and chemical properties, cerium oxide has been widely concerned as a widely used nanomaterials, especially in the field of medicine. More and more studies have shown that cerium oxide nanoparticles have antioxidant, anticancer, antibacterial and neuroprotective effects, these effects were achieved by mimicking the mechanisms of natural enzyme activity, inducing apoptosis of cancer cells, inhibiting abnormal vascular growth, destroying bacterial cell walls and reactive oxygen species. This article reviews the biological activity and mechanism of nano-cerium oxide in many aspects, hoping to provide reference for biomedical medicine and clinical application of nano-cerium oxide.
作者 王皓 姚青 杨阳 高春生 韩翠艳 WANG Hao;YAO Qing;YANG Yang;GAO Chunsheng;HAN Cuiyan(School of Pharmacy,Qiqihar Medical College,Qiqihar 161006,China;Shenyang Pharmaceutical University,Shenyang 110016,China;Institute of Toxicology,Institute of Military Medicine,Academy of Military Sciences,Beijing 100850,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2021年第17期2170-2179,共10页 Chinese Journal of Modern Applied Pharmacy
基金 黑龙江省自然科学基金项目(LH2020H134)。
关键词 纳米氧化铈 医药领域 生物医学 cerium oxide nanoparticles medical field biomedical medicine
  • 相关文献

参考文献9

二级参考文献40

  • 1于冰,孙治君.凋亡相关基因bcl-2、bax、bad与乳腺癌[J].中国普外基础与临床杂志,2007,14(6):739-742. 被引量:18
  • 2Alzheimer's Association. 2012 Alzheimer's disease facts and fig- ures [ J ]. Alzheimers Dement, 2012 : 131 - 168. 被引量:1
  • 3Jack CR Jr, Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease [J]. Alzheimers Dement, 2011, 7(3) : 257 -262. 被引量:1
  • 4Kang JH, Ryoo NY, Shin DW, et al. Role of cerebrospinal fluid biornarkers in clinical trials for Alzheimer's disease modifying them- pies [J]. Korean J Physiol Pharmacol, 2014, 18(6): 447 -456. 被引量:1
  • 5Maia LF, Kaeser SA, Reichwald J, et al. Increased CSF Abeta during the very early phase of cerebral Abcta deposition in mouse models [J]. EMBO Mol Med, 2015, 7(7) : 895 -903. 被引量:1
  • 6Pan C, Korff A, Galasko D, et al. Diagnostic values of cerebrospinal fluid T-Tau and A1342 using meso scale discovery assays for Alzhei- mer's disease [J]. J Alzheimers Dis, 2015, 45(3) : 709 -719. 被引量:1
  • 7Pate1 VB, Misra S, Patel BB, et al. Colorectal cancer: chemo- preventive role of curcumin and resveratrol [J]. Nutr Cancer, 2010, 62(7) : 958 -967. 被引量:1
  • 8Wongcharoen W, Phrommintikul A. The protective role of curcu- rain in cardiovascular diseases [ J]. Int J Cardiol, 2009, 133 (2) : 145 -151. 被引量:1
  • 9Shehzad A, Wahid F, Lee YS. Curcumin in cancer chemopre- vention: molecular targets, pharmacokinetics, bioavailability, and clinical trials [J]. Arch Pharm (Weinheim) , 2010, 343 (9) : 489 -499. 被引量:1
  • 10Liu X, Zuo H, Wang D, et al. Improvement of spatial memory disorder and hippocampal damage by exposure to electromagnetic fields in an Alzheimcr's disease rat model [ J ]. PLoS One, 2015, 10(5): e0126963. 被引量:1

共引文献47

同被引文献52

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部